The post Eli Lilly Growing at 55% as a Trillion-Dollar Company: ‘These Are NVIDIA-Like Growth Numbers’ appeared first on 24/7 Wall St..
Quick Read
Macro strategist Jordi Visser calls Eli Lilly (LLY) an AI investment rather than just pharma because it grew Q1 2026 revenue 55.5% YoY, matching NVIDIA-level growth rates.
Eli Lilly’s AI partnerships with Insilico Medicine, Isomorphic Labs, and NVIDIA are positioning it to transform drug discovery …